# Rodney Sinclair

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rodney-sinclair/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,840 |
| Field | Hair Growth and Disorders |
| h-index | 76 |
| i10-index | 378 |
| Last Known Institution | The University of Melbourne |
| OpenAlex ID | https://openalex.org/A5035044854 |
| ORCID iD | https://orcid.org/0000-0001-6751-1428 |
| Works | 843 |

## Researcher papers

- [Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials](https://scholariq.org/papers/tildrakizumab-versus-placebo-or-etanercept-for-chronic-plaque-psoriasis/)
- [Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-abrocitinib-in-adults-and-adolescents-with-moderate-to/)
- [Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity](https://scholariq.org/papers/development-and-validation-of-the-international-hidradenitis-suppurativa/)
- [Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis](https://scholariq.org/papers/abrocitinib-versus-placebo-or-dupilumab-for-atopic-dermatitis/)
- [Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials](https://scholariq.org/papers/secukinumab-in-moderate-to-severe-hidradenitis-suppurativa-sunshine-and-sunrise/)
- [Ligelizumab for Chronic Spontaneous Urticaria](https://scholariq.org/papers/ligelizumab-for-chronic-spontaneous-urticaria/)

## Researcher topics

- [Hair Growth and Disorders](https://scholariq.org/topics/hair-growth-and-disorders/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Dermatologic Treatments and Research](https://scholariq.org/topics/dermatologic-treatments-and-research/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Skin and Cellular Biology Research](https://scholariq.org/topics/skin-and-cellular-biology-research/)

## Researcher university

- [The University of Melbourne](https://scholariq.org/institutions/the-university-of-melbourne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.